About DuneX Biosciences
Based in the East Bay Area of San Francisco, DuneX Biosciences is a biotechnology Contract Research Organization empowering drug discovery through genome-wide CRISPR screening and yeast display antibody discovery platforms.
What We Do
CRISPR Functional Genomics
We provide genome-wide and custom CRISPR knockout or activation screening services to identify essential genes, drug resistance mechanisms, and synthetic lethal interactions. Our end-to-end workflow covers library design, screening, sequencing, and data analysis.
Yeast Display Antibody Discovery
Our high-diversity yeast display platform enables rapid discovery of high-affinity antibodies and bispecifics. Through multi-round FACS-based selection and affinity maturation, we deliver validated antibody sequences ready for therapeutic development.
Our Expertise
The DuneX team brings together deep expertise in CRISPR functional genomics, antibody discovery, T-cell engagers, and molecular biology automation — combining academic rigor with industry experience from leading biotech and pharmaceutical organizations.
Our Facilities
We operate within the Bonneville Labs network in Hayward, CA, providing access to state-of-the-art shared instrumentation, FACS sorters, BSL-2 laboratories, and molecular biology suites. Our location in the Bay Area innovation hub enables rapid collaboration with academic, biotech, and pharma partners.
Our Innovations and Milestones
CRISPR Advancements
Developed state-of-the-art genome-wide CRISPR screening methods enhancing target discovery efficiency.
Yeast Display Technology
Pioneered advanced yeast display techniques facilitating rapid antibody development and optimization.
Strategic Partnerships
Forged collaborations with top biotech firms to accelerate research and development initiatives.
